IBM Collaborates with FDA on Blockchain Health Data

“The healthcare industry is undergoing significant changes due to the vast amounts of disparate data being generated. Blockchain technology provides a highly secure, decentralised framework for data sharing that will accelerate innovation throughout the industry,” said Shahram Ebadollahi, vice president for innovations and chief science officer, IBM Watson Health.

Engility to Build Up HPC at FDA

“With this award, Engility expands on our long-standing partnership with the FDA to further develop their high performance computing and complex data analysis capabilities,” said Engility CEO Lynn Dugle. “We look forward to supporting the FDA’s mission to make groundbreaking treatments, such as genetics-based medicine, available to all Americans.”